Impact of withdrawal of fusafungine from the market on the prescribing of alternative treatments in Germany (Fusafungine impact study)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/34098
• EU PAS number:
  EUPAS24430
• Study ID:
  34098
• Official title and acronym:
  Impact of withdrawal of fusafungine from the market on the prescribing of alternative treatments in Germany (Fusafungine impact study)
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study status:
  Finalised

Research institutions and networks

Institutions

European Medicines Agency (EMA)

Study timelines

Date when funding contract was signed

Planned: 18/12/2015

Actual: 18/12/2015

Study start date

Planned: 15/08/2017

Actual: 15/08/2017

Data analysis start date

Planned: 15/08/2017

Actual: 15/08/2017

Date of final study report

Planned: 30/06/2018

Actual: 01/12/2019

Sources of funding

EMA

Study protocol

Initial protocol

PASS_protocol

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable